Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain.

Rohn TT, Catlin LW.

PLoS One. 2011;6(5):e20495. doi: 10.1371/journal.pone.0020495. Epub 2011 May 31.

2.

Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.

Langley J, Huddleston DE, Sedlacik J, Boelmans K, Hu XP.

Mov Disord. 2017 Mar;32(3):441-449. doi: 10.1002/mds.26883. Epub 2016 Dec 22.

PMID:
28004859
3.

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.

Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A.

Neuroreport. 2006 Jul 31;17(11):1215-8.

PMID:
16837857
5.

Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.

Hill WD, Arai M, Cohen JA, Trojanowski JQ.

J Comp Neurol. 1993 Mar 15;329(3):328-36.

PMID:
8459049
6.

The enigma of neuromelanin in Parkinson's disease substantia nigra.

Youdim MB, Ben-Shachar D, Riederer P.

J Neural Transm Suppl. 1994;43:113-22. Review.

PMID:
7884393
7.

Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.

Wüllner U, Kornhuber J, Weller M, Schulz JB, Löschmann PA, Riederer P, Klockgether T.

Acta Neuropathol. 1999 Apr;97(4):408-12.

PMID:
10208281
8.

Neuromelanin and Parkinson's disease.

Marsden CD.

J Neural Transm Suppl. 1983;19:121-41.

PMID:
6321645
9.

Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

Takahashi H, Watanabe Y, Tanaka H, Mihara M, Mochizuki H, Liu T, Wang Y, Tomiyama N.

Br J Radiol. 2018 Jun;91(1086):20180037. doi: 10.1259/bjr.20180037. Epub 2018 May 17.

PMID:
29498540
10.

Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease.

Depboylu C, Schäfer MK, Arias-Carrión O, Oertel WH, Weihe E, Höglinger GU.

J Neuropathol Exp Neurol. 2011 Feb;70(2):125-32. doi: 10.1097/NEN.0b013e31820805b9.

PMID:
21343881
11.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.

PMID:
16000336
12.
13.

Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.

Reimão S, Pita Lobo P, Neutel D, Correia Guedes L, Coelho M, Rosa MM, Ferreira J, Abreu D, Gonçalves N, Morgado C, Nunes RG, Campos J, Ferreira JJ.

Eur J Neurol. 2015 Mar;22(3):540-6. doi: 10.1111/ene.12613. Epub 2014 Dec 22.

PMID:
25534480
14.

Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.

Aimé P, Sun X, Zareen N, Rao A, Berman Z, Volpicelli-Daley L, Bernd P, Crary JF, Levy OA, Greene LA.

J Neurosci. 2015 Jul 29;35(30):10731-49. doi: 10.1523/JNEUROSCI.0614-15.2015.

15.

Viral etiology for Parkinson's disease--a possible role of influenza A virus infection.

Takahashi M, Yamada T.

Jpn J Infect Dis. 1999 Jun;52(3):89-98. Review.

PMID:
10507986
16.

T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.

Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP.

Mov Disord. 2011 Aug 1;26(9):1633-8. doi: 10.1002/mds.23722. Epub 2011 Apr 12. Erratum in: Mov Disord. 2012 Feb;27(2):335.

PMID:
21491489
17.

Apoptosis in Parkinson's disease: signals for neuronal degradation.

Tatton WG, Chalmers-Redman R, Brown D, Tatton N.

Ann Neurol. 2003;53 Suppl 3:S61-70; discussion S70-2. Review.

PMID:
12666099
18.

Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.

Reimão S, Ferreira S, Nunes RG, Pita Lobo P, Neutel D, Abreu D, Gonçalves N, Campos J, Ferreira JJ.

Eur J Neurol. 2016 Feb;23(2):368-74. doi: 10.1111/ene.12838. Epub 2015 Oct 31.

PMID:
26518135
19.

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC.

J Neurochem. 2001 Mar;76(6):1785-93.

20.

Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.

Fasano M, Giraudo S, Coha S, Bergamasco B, Lopiano L.

Neurochem Int. 2003 Jun;42(7):603-6.

PMID:
12590943

Supplemental Content

Support Center